PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IDXX vs. EXAS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IDXX and EXAS is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

IDXX vs. EXAS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IDEXX Laboratories, Inc. (IDXX) and Exact Sciences Corporation (EXAS). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
-16.19%
9.12%
IDXX
EXAS

Key characteristics

Sharpe Ratio

IDXX:

-0.92

EXAS:

-0.36

Sortino Ratio

IDXX:

-1.25

EXAS:

-0.16

Omega Ratio

IDXX:

0.85

EXAS:

0.98

Calmar Ratio

IDXX:

-0.59

EXAS:

-0.29

Martin Ratio

IDXX:

-1.48

EXAS:

-0.92

Ulcer Index

IDXX:

16.90%

EXAS:

22.80%

Daily Std Dev

IDXX:

27.11%

EXAS:

58.70%

Max Drawdown

IDXX:

-81.46%

EXAS:

-98.01%

Current Drawdown

IDXX:

-40.68%

EXAS:

-65.03%

Fundamentals

Market Cap

IDXX:

$34.28B

EXAS:

$10.03B

EPS

IDXX:

$10.34

EXAS:

-$1.16

PEG Ratio

IDXX:

4.45

EXAS:

-1.07

Total Revenue (TTM)

IDXX:

$2.94B

EXAS:

$2.05B

Gross Profit (TTM)

IDXX:

$1.81B

EXAS:

$1.47B

EBITDA (TTM)

IDXX:

$977.28M

EXAS:

$14.62M

Returns By Period

In the year-to-date period, IDXX achieves a 1.26% return, which is significantly higher than EXAS's -3.54% return. Over the past 10 years, IDXX has outperformed EXAS with an annualized return of 18.09%, while EXAS has yielded a comparatively lower 7.00% annualized return.


IDXX

YTD

1.26%

1M

-3.12%

6M

-16.19%

1Y

-21.79%

5Y*

7.66%

10Y*

18.09%

EXAS

YTD

-3.54%

1M

-11.51%

6M

9.12%

1Y

-19.25%

5Y*

-9.64%

10Y*

7.00%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IDXX vs. EXAS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDXX
The Risk-Adjusted Performance Rank of IDXX is 99
Overall Rank
The Sharpe Ratio Rank of IDXX is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of IDXX is 88
Sortino Ratio Rank
The Omega Ratio Rank of IDXX is 1010
Omega Ratio Rank
The Calmar Ratio Rank of IDXX is 1313
Calmar Ratio Rank
The Martin Ratio Rank of IDXX is 77
Martin Ratio Rank

EXAS
The Risk-Adjusted Performance Rank of EXAS is 3030
Overall Rank
The Sharpe Ratio Rank of EXAS is 3030
Sharpe Ratio Rank
The Sortino Ratio Rank of EXAS is 3131
Sortino Ratio Rank
The Omega Ratio Rank of EXAS is 3030
Omega Ratio Rank
The Calmar Ratio Rank of EXAS is 3232
Calmar Ratio Rank
The Martin Ratio Rank of EXAS is 2929
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IDXX vs. EXAS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for IDEXX Laboratories, Inc. (IDXX) and Exact Sciences Corporation (EXAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for IDXX, currently valued at -0.92, compared to the broader market-2.000.002.00-0.92-0.36
The chart of Sortino ratio for IDXX, currently valued at -1.25, compared to the broader market-4.00-2.000.002.004.00-1.25-0.16
The chart of Omega ratio for IDXX, currently valued at 0.85, compared to the broader market0.501.001.502.000.850.98
The chart of Calmar ratio for IDXX, currently valued at -0.59, compared to the broader market0.002.004.006.00-0.59-0.29
The chart of Martin ratio for IDXX, currently valued at -1.48, compared to the broader market0.0010.0020.00-1.48-0.92
IDXX
EXAS

The current IDXX Sharpe Ratio is -0.92, which is lower than the EXAS Sharpe Ratio of -0.36. The chart below compares the historical Sharpe Ratios of IDXX and EXAS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50AugustSeptemberOctoberNovemberDecember2025
-0.92
-0.36
IDXX
EXAS

Dividends

IDXX vs. EXAS - Dividend Comparison

Neither IDXX nor EXAS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

IDXX vs. EXAS - Drawdown Comparison

The maximum IDXX drawdown since its inception was -81.46%, smaller than the maximum EXAS drawdown of -98.01%. Use the drawdown chart below to compare losses from any high point for IDXX and EXAS. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%AugustSeptemberOctoberNovemberDecember2025
-40.68%
-65.03%
IDXX
EXAS

Volatility

IDXX vs. EXAS - Volatility Comparison

The current volatility for IDEXX Laboratories, Inc. (IDXX) is 7.09%, while Exact Sciences Corporation (EXAS) has a volatility of 12.28%. This indicates that IDXX experiences smaller price fluctuations and is considered to be less risky than EXAS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%AugustSeptemberOctoberNovemberDecember2025
7.09%
12.28%
IDXX
EXAS

Financials

IDXX vs. EXAS - Financials Comparison

This section allows you to compare key financial metrics between IDEXX Laboratories, Inc. and Exact Sciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab